Fingerprint
Dive into the research topics of 'Pathologic complete response to preoperative sequential foxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically